Novel Therapies Symposium

The call for submissions for the Novel Therapies Symposium at the 38th ECNP Congress 2025 is closed. This Symposium is dedicated to clinical trials of new compounds, including proof of concept and post-marketing studies, using data from human trials, especially phase II and III trials. We strive for studies which have not yet been published as journal articles.

New Medication or Medical Device

Advances in medications and medical devices: application of new drugs and technology in clinical settings.

This year, we will also provided the opportunity to submit studies using new medical devices, e.g. neurostimulation technologies.

How to submit

If you were interested in presenting your new medication or device at the 38th ECNP congress, the following details needed to be uploaded:

  • A suggested speaker and back-up speaker (name, country, e-mail)
  • A presentation title (max. 20 words) 
  • A summary explaining the content of the presentation (max. 250 words) 
  • A short motivation: why is it important that these findings are shared? 

The deadline to submit was 15 May 2025. All submissions will be reviewed by the SPC for acceptance, the outcome of the review will be communicated before 18 June 2025.   

Further information

Selected speakers will receive:

  • Approximately 15 minutes to present their research
  • Reimbursement of travel and accommodation costs.  

We accepted submissions from both academia and industry.